Top Buy
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Viracta Therapeutics Inc. | 1 | 0 | 1 | 0 | €0.75 | - | - |
| Amgen Inc. | 25 | 0 | 6 | 0 | €287.90 | €297.31 | 3.269% |
| Quest Diagnostics Inc. | 4 | 0 | 1 | 0 | €128.50 | €144.44 | 12.408% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.20 | €21.66 | -6.642% |
| Centene Corp. | 15 | 0 | 3 | 0 | €72.22 | €82.57 | 14.332% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €93.00 | €124.85 | 34.245% |
| Stryker Corp. | 23 | 0 | 7 | 0 | €306.90 | €335.03 | 9.165% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €70.56 | €80.00 | 13.379% |
| Geron Corp. | 12 | 0 | 2 | 0 | €3.53 | €4.63 | 30.968% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €75.50 | €75.94 | 0.577% |
| CONMED Corp. | 12 | 1 | 4 | 0 | €64.00 | €106.18 | 65.905% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €38.00 | €84.74 | 123.011% |
| Intellia Therapeutics Inc | 13 | 1 | 1 | 1 | €22.72 | €60.55 | 166.523% |
| Corvus Pharmaceuticals Inc | 5 | 1 | 1 | 0 | €1.86 | €6.45 | 247.662% |
| Bruker Corp. | 7 | 1 | 0 | 0 | €70.30 | €85.68 | 21.884% |
| Abeona Therapeutics Inc. | 3 | 1 | 1 | 0 | €3.90 | €34.41 | 782.374% |
| Edwards Lifesciences Corp. | 26 | 1 | 3 | 0 | €80.49 | €88.14 | 9.501% |
| Xencor Inc. | 10 | 1 | 2 | 0 | €22.60 | €32.58 | 44.154% |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.90 | €5.51 | 515.469% |
| Henry Schein Inc. | 12 | 1 | 1 | 0 | €67.70 | €79.48 | 17.399% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €15.32 | - | - |
| Stoke Therapeutics Inc | 15 | 1 | 2 | 0 | €11.10 | €21.00 | 89.222% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €39.40 | €50.00 | 26.904% |
| Cytokinetics Inc. | 27 | 1 | 3 | 0 | €58.00 | €85.64 | 47.661% |
| MacroGenics Inc. | 14 | 1 | 5 | 1 | €3.07 | €14.25 | 363.696% |